CA2170355A1 - Allergenes d'alternaria alternaria recombinants - Google Patents

Allergenes d'alternaria alternaria recombinants

Info

Publication number
CA2170355A1
CA2170355A1 CA002170355A CA2170355A CA2170355A1 CA 2170355 A1 CA2170355 A1 CA 2170355A1 CA 002170355 A CA002170355 A CA 002170355A CA 2170355 A CA2170355 A CA 2170355A CA 2170355 A1 CA2170355 A1 CA 2170355A1
Authority
CA
Canada
Prior art keywords
gly
recombinant
leu
allergens
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002170355A
Other languages
English (en)
Inventor
Gernot Achatz
Hannes Oberkofler
Birgit Simon
Andrea Unger
Erich Lechenauer
Reinhold Hirschwehr
Christoph Ebner
Dietrich Kraft
Hans-Jorg Prillinger
Michael Breitenbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomay AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2170355A1 publication Critical patent/CA2170355A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention se rapporte à des molécules d'ADN recombinées qui codent pour des polypeptides qui possèdent l'antigénicité des allergènes Alta53, Alta22 et Alta11 ou pour des peptides présentant au moins un épitope de ces allergènes. Ces molécules sont caractérisées en ce qu'elles présentent des séquences d'acide nucléique qui concordent, de façon homologue, avec les séquences 1, 3-5, 7-9, 12 et 13, ou avec des domaines partiels de ces séquences, ou des séquences d'acide nucléique hybridées avec les séquences d'acide nucléique précitées dans des conditions sévères.
CA002170355A 1993-08-27 1994-08-24 Allergenes d'alternaria alternaria recombinants Abandoned CA2170355A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0172693A AT400723B (de) 1993-08-27 1993-08-27 Rekombinante alternaria alternata allergene
ATA1726/93 1993-08-27
PCT/AT1994/000121 WO1995006122A2 (fr) 1993-08-27 1994-08-24 Allergenes recombines d'alternaria alternata

Publications (1)

Publication Number Publication Date
CA2170355A1 true CA2170355A1 (fr) 1995-03-02

Family

ID=3519690

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002170355A Abandoned CA2170355A1 (fr) 1993-08-27 1994-08-24 Allergenes d'alternaria alternaria recombinants

Country Status (8)

Country Link
EP (1) EP0714442A1 (fr)
JP (1) JPH09503654A (fr)
AT (1) AT400723B (fr)
AU (1) AU7377294A (fr)
CA (1) CA2170355A1 (fr)
FI (1) FI960882A7 (fr)
NO (1) NO960748L (fr)
WO (1) WO1995006122A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
AU773028B2 (en) * 1998-11-03 2004-05-13 Adherex Technologies Inc. Compounds and methods for modulating claudin-mediated functions
US6756356B2 (en) 1998-11-03 2004-06-29 Adherex Technologies, Inc. Compounds and methods for modulating claudin-mediated functions
GB201209868D0 (en) * 2012-06-01 2012-07-18 Circassia Ltd Alternaria peptides

Also Published As

Publication number Publication date
NO960748L (no) 1996-04-24
AT400723B (de) 1996-03-25
WO1995006122A2 (fr) 1995-03-02
FI960882L (fi) 1996-04-24
FI960882A7 (fi) 1996-04-24
WO1995006122A3 (fr) 1995-07-13
ATA172693A (de) 1995-07-15
NO960748D0 (no) 1996-02-23
EP0714442A1 (fr) 1996-06-05
AU7377294A (en) 1995-03-21
JPH09503654A (ja) 1997-04-15
FI960882A0 (fi) 1996-02-26

Similar Documents

Publication Publication Date Title
KR20210006460A (ko) 바리셀라 조스터 바이러스의 항원 변이체 및 이의 용도
JPH08504177A (ja) 免疫調節ペプチド
JP3575802B2 (ja) 日本杉花粉からのアレルゲン性蛋白質及びペプチド
JPH08502244A (ja) 免疫調節ペプチド
EP0688338A1 (fr) Determinants antigeniques de lymphocites t de l'allergene contenu dans le pollen du ray-grass
EA020792B1 (ru) Пептиды трав для вакцины
US5710126A (en) T cell epitopes of ryegrass pollen allergen
US20150079120A1 (en) Dna sequence and preparation of grass pollen allergen phl p4 by recombinant methods
JPH09504167A (ja) ドクムギ花粉アレルゲンのｔ細胞エピトープ
US20150210742A1 (en) Novel allergen from ragweed pollen and uses thereof
CA2170355A1 (fr) Allergenes d'alternaria alternaria recombinants
CA2170356A1 (fr) Allergenes de cladosporium herbarum recombinants
JPH08502163A (ja) 杉花粉由来のアレルゲン性蛋白質及びペプチド
CA2370393C (fr) Sequence d'adn et production par recombinaison d'un allergene de gramines
AU2014328483A1 (en) Novel immunotherapeutic composition and uses thereof
US20170246317A1 (en) Dna sequence, and recombinant preparation of group 4 major allergens from cereals
US7112333B1 (en) T cell epitopes of ryegrass pollen allergen
WO1992016554A1 (fr) Allergenes proteiques de l'espece cynodon dactylon
KR20070035805A (ko) 재조합 아세틸콜린 수용체 폴리펩티드, 폴리펩티드 유도체및 이를 유효성분으로 포함하는 중증근무력증 치료제
CA2204362A1 (fr) Allergenes d'alternaria alternata recombines
AU2012205288B2 (en) DNA-sequence and recombinant production of group 4 major allergens from cereals
EP2281836B1 (fr) Protéines hybrides d'allergènes de Parietaria major et leurs utilisations
ITMI20112301A1 (it) Varianti ipoallergeniche dell'allergene maggiore phl p 5 di phleum pratense

Legal Events

Date Code Title Description
FZDE Discontinued